Recce Pharmaceuticals Ltd

NEW
ASX:RCE (Australia)  
A$ 0.38 -0.0050 (-1.32%) Jul 8
At Loss
Market Cap:
A$ 113.80M ($ 78.75M)
Enterprise V:
A$ 124.14M ($ 85.91M)
Volume:
168.00K
Avg Vol (2M):
202.04K
Trade In:
Volume:
168.00K
At Loss
Avg Vol (2M):
202.04K

Recce Pharmaceuticals Ltd (ASX:RCE) Dividend

Recce Pharmaceuticals Ltd (ASX:RCE) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -16.8%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: ASX:RCE Dividend

Does Recce Pharmaceuticals Ltd (ASX:RCE) pay a dividend?

Recce Pharmaceuticals Ltd (ASX:RCE) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Recce Pharmaceuticals Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Recce Pharmaceuticals Ltd has returned capital to shareholders via buybacks at a rate of -16.8% over the past 3 years.

What are dividend-paying alternatives to Recce Pharmaceuticals Ltd?

For dividend-paying alternatives in Recce Pharmaceuticals Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.